Development of a Standardized Electronic Treatment Plan Builds for NCI-supported Clinical Trials Year 2
Development of a Standardized Electronic Treatment Plan Builds for NCI-supported Clinical Trials Year 2
批准号:
10440230
负责人:
Eric R. Fearon
金额:
$30.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-01 至 2022-05-31
关键词:
CaringClinical TrialsCollaborationsComplexDataDevelopmentDiseaseElectronic Health RecordGoalsGuidelinesHealthHealth systemHealthcareInformaticsInstitutionInstitutional Review BoardsInvestigationMeasuresMethodsNational Cancer InstituteOncologyPatient CarePatientsProtocols documentationRegimenResearch ProposalsResearch SupportSiteStandardizationSurveysSystemTimeTime StudyTreatment ProtocolsVariantWorkanticancer researchbasememberoperationresearch studystandard of caresymptom managementtreatment planning
中文摘要
医疗机构利用电子医疗记录(EHR)为患者提供详细的治疗支持
英文摘要
Healthcare institutions utilize electronic healthcare records (EHR) to support patients with elaborate treatment
plans, specifically those related to oncology regimens. These treatment plans traditionally are created in
accordance to the respective institutions’ content expert, EHR configuration, and local guidelines for standard
of care. Many research studies with investigational agents also contain complex treatment regimens which
undergo the same workflow and scrutiny before implementation. Many of these studies are implemented
across several health institutions, including those initiated by the National Cancer Institute (NCI). Multisite
studies have an inherent need to be standardized across sites to reduce variation. However, because
institutions utilize local EHR configuration, standards of care, and content experts to create these study
treatment plans from scratch, unnecessary study variations between participating site cans exist. Furthermore,
delay in study implementation may exist as a result of each health system’s need to identify disease, study,
and EHR build experts who can commit time for study collaboration and implementation. The goal of this
project is to develop a consortium for standardizing NCI supported EHR treatment plans to alleviate
study variation and time-to-implementation for participating sites. The project plan involves establishing a
subcommittee of experts within a pre-existing group known as the Big Ten Cancer Research Consortium. This
consortium consists of members with significant participation in NCI supported research studies. Members
from this consortium will include experts in NCI-related studies, EHR build creation, as well as management in
research proposals and informatics operations. This group will convene regularly to compare previous NCI
sponsored treatment plans within their respective EHR to develop agreed upon standards for creating NCI
protocols in the EHR. These standards will then be utilized to create treatment plan templates for participating
institutions to integrate within their respective EHR systems. Measures to analyze successful implementation
will be time related data concerned with duration of implementation from request, initial IRB approval to study
activation, and survey data related to the template’s ease of use and interpretation. The consortium will review
these data regularly for improvement and feasibility to continue work in standardizing treatment plans. This
work will be shared among participating EHR and NCI members.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Research Program
-
批准号:10554479
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2023
-
负责人:Eric R. Fearon
-
依托单位:
Development of a Standardized Electronic Treatment Plan Builds for NCI-supported Clinical Trials
-
批准号:10226720
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2020
-
负责人:Eric R. Fearon
-
依托单位:
Development Research Program
-
批准号:7893341
-
项目类别:
-
资助金额:$8.12万
-
财政年份:2010
-
负责人:Eric R. Fearon
-
依托单位:
PROGRAM LEADERS
-
批准号:7304457
-
项目类别:
-
资助金额:$24.71万
-
财政年份:2006
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6085912
-
项目类别:
-
资助金额:$26.81万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:7238864
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:6985089
-
项目类别:
-
资助金额:$28.36万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6633647
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6751499
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6377771
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6514406
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:7125946
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:7420984
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:7617644
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
COLON TUMOR PROJECT
-
批准号:6300693
-
项目类别:
-
资助金额:$10.37万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer
-
批准号:6919312
-
项目类别:
-
资助金额:$29.55万
-
财政年份:1999
-
负责人:Eric R. Fearon
-
依托单位:
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer
-
批准号:8037373
-
项目类别:
-
资助金额:$27.13万
-
财政年份:1999
-
负责人:Eric R. Fearon
-
依托单位:
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer
-
批准号:8700327
-
项目类别:
-
资助金额:$26.31万
-
财政年份:1999
-
负责人:Eric R. Fearon
-
依托单位:
CDX2 TUMOR SUPPRESSOR PATHWAY DEFECTS IN COLON CANCER
-
批准号:2881974
-
项目类别:
-
资助金额:$22.33万
-
财政年份:1999
-
负责人:Eric R. Fearon
-
依托单位:
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer
-
批准号:8515745
-
项目类别:
-
资助金额:$25.5万
-
财政年份:1999
-
负责人:Eric R. Fearon
-
依托单位:
海外基金